Market Research Logo

Analyzing Generics Market in Indonesia 2017

A. Executive Summary
B. Analyzing the Global Generics Industry
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast
C. Generics Industry in Asia Pacific
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast
D. Generics Industry in Indonesia
D.1 Industry Overview
D.2 Industry Value & Volume
D.3 Industry Segmentation by Geography
D.4 Industry Forecast
E. Generics Industry in Indonesia: Porter’s Five Forces Strategy Analysis
E.1 Introduction
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes
F. Major Industry Players
F.1 Allergan Plc
F.1.1 Corporate Analysis
F.1.2 Financial Analysis
F.1.3 SWOT Analysis
F.2 Cipla Limited
F.2.1 Corporate Analysis
F.2.2 Financial Analysis
F.2.3 SWOT Analysis
F.3 Lupin Limited
F.3.1 Corporate Analysis
F.3.2 Financial Analysis
F.3.3 SWOT Analysis
F.4 PT Kalbe Farma Tbk
F.4.1 Corporate Analysis
F.4.2 Financial Analysis
F.4.3 SWOT Analysis
F.5 Teva Pharmaceutical Industries Limited
F.5.1 Corporate Analysis
F.5.2 Financial Analysis
F.5.3 SWOT Analysis
F.6 PT Indofarma (Persero), Tbk
F.7 PT Sanbe Farma
F.8 PT Soho Global Health
G. Glossary of Terms
List of Figures
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
Figure 11: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
Figure 12: Share of the Asia Pacific Generics Industry by Countries (%), 2016
Figure 13: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
Figure 15: Value of the Generics Market in Indonesia (in USD Billion), 2012-2016
Figure 16: Volume Growth of the Generics Market in Indonesia (%), 2012-2016
Figure 17: Share of Indonesia in the Asia Pacific Generics Industry (%), 2016
Figure 18: Forecast of the Generics Market in Indonesia (in USD Billion), 2016-2021
Figure 19: Volume Forecast of the Generics Market in Indonesia (%), 2016-2021
Figure 20: Porter's Five Forces Strategy Analysis of the Generics Industry in Indonesia
Figure 21: Bargaining Power of Buyers in the Indonesian Generics Industry
Figure 22: Bargaining Power of Suppliers in the Indonesian Generics Industry
Figure 23: Competitive Rivalry in the Indonesian Generics Industry
Figure 24: Threat of New Entrants to the Indonesian Generics Industry
Figure 25: Threat of Substitutes to the Indonesian Generics Industry
Figure 26: Revenues & Profitability of Allergan Plc (in USD Million), 2011-2015
Figure 27: Revenues & Profitability of Cipla Limited (in USD Million), 2011-2015
Figure 28: Revenues & Profitability of Lupin (in USD Million), 2011-2015
Figure 29: Revenues & Profitability of PT Kalbe Farma Tbk (in USD Million), 2011-2015
Figure 30: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015
Figure 31: Revenues & Profitability of PT Indofarma (Persero) (in USD Million), 2011-2015
List of Tables
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
Table 7: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
Table 8: Share of the Asia Pacific Generics Industry by Countries (% & USD Billion), 2016
Table 9: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
Table 10: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
Table 11: Value of the Generics Market in Indonesia (in USD Billion), 2012-2016
Table 12: Volume Growth of the Generics Market in Indonesia (%), 2012-2016
Table 13: Share of Indonesia in the Asia Pacific Generics Industry (in USD Billion & %), 2016
Table 14: Forecast of the Generics Market in Indonesia (in USD Billion), 2016-2021
Table 15: Volume Forecast of the Generics Market in Indonesia (%), 2016-2021
Table 16: Key Financials of Allergan Plc (in USD Million), 2011-2015
Table 17: Key Financials of Cipla Limited (in USD Million), 2011-2015
Table 18: Key Financials of Lupin (in USD Million), 2011-2015
Table 19: Key Financials of PT Kalbe Farma Tbk (in USD Million), 2011-2015
Table 20: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015
Table 21: Key Financials of PT Indofarma (Persero) (in USD Million), 2011-2015

Analyzing Generics Market in Indonesia 2017

Indonesia has been growing strongly as a hub for the manufacturing of generic drugs. In the Asia Pacific region, Indonesia has emerged as one of the major manufacturing hubs for generics. In fact, the growth of generics is further expected to grow in the country as the government puts in place the country's first compulsory national health insurance system, known as Jaminan Kesehatan Nasional (JKN).

In 2016, the Indonesian generics market had revenues of over USD 910 million and it is expected that by the end of 2021, the market will generate revenues of over USD 1.5 billion. Having several domestic players actively leading the industry, the growth of the industry looks secure as compared to its regional counterparts.

Aruvian Research presents Analyzing Generics Market in Indonesia 2017 – a comprehensive coverage of the Indonesian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.

Moving on, we analyze the Generics Industry in Asia Pacific through the same parameters.

The Generics Industry in Indonesia is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.

We also include a Porter’s Five Forces analysis of the Indonesian Generics Industry. Generics pricing and reimbursement situation in Indonesia and trends and challenges facing the industry are analyzed.

Analysis of the major industry players in the Indonesian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include. This concludes this comprehensive research report from Aruvian Research.

This research report helps you get an insider’s look at the Indonesian generic industry and helps you understand what the future holds for the industry. Comparison of the Indonesian market with its regional counterparts, market value and volume output, competitive landscape - all these data points makes this report an essential resource for analytical purposes.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;